EVMN
Evommune, Inc.
9.50$
-2.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2023 | 2024 | 2025 |
|---|---|---|---|
| 100.0% | 100.0% | 100.0% | |
| 97.3% | 97.3% | 68.2% | |
| 35.3% | 21.4% | 19.6% | |
| 96.2% | 94.7% | 66.3% | |
| 194.5% | 289.6% | 8.6% | |
| 8.3% | 36.8% | 8.0% | |
| 0.9% | 1.3% | 0.3% | |
| 2.1% | 10.9% | 3.4% | |
| -94.5% | -189.6% | 91.4% | |
| -102.0% | -200.1% | -98.3% | |
| 36.6% | 39.5% | 14.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.